Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Baxter International Inc. (BAX : NYSE)
 
 • Company Description   
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.

Number of Employees: 60,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $74.34 Daily Weekly Monthly
20 Day Moving Average: 3,455,895 shares
Shares Outstanding: 503.53 (millions)
Market Capitalization: $37,432.32 (millions)
Beta: 0.62
52 Week High: $89.70
52 Week Low: $69.72
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -2.84% 6.04%
12 Week -11.98% -7.33%
Year To Date -13.40% 0.95%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
One Baxter Parkway
-
Deerfield,IL 60015
USA
ph: 224-948-2000
fax: 224-948-1813
global_corp_investor_relations@baxter.com http://www.baxter.com
 
 • General Corporate Information   
Officers
Jose E. Almeida - Chairman and Chief Executive Officer
James K. Saccaro - Executive Vice President and Chief Financial Offic
Brian C. Stevens - Senior Vice President; Chief Accounting Officer an
Michael F. Mahoney - Director
Nancy M. Schlichting - Director

Peer Information
Baxter International Inc. (BJCT)
Baxter International Inc. (CADMQ)
Baxter International Inc. (APNO)
Baxter International Inc. (UPDC)
Baxter International Inc. (IMTIQ)
Baxter International Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 071813109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 503.53
Most Recent Split Date: 5.00 (2.00:1)
Beta: 0.62
Market Capitalization: $37,432.32 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 1.51%
Current Fiscal Quarter EPS Consensus Estimate: $0.88 Indicated Annual Dividend: $1.12
Current Fiscal Year EPS Consensus Estimate: $4.16 Payout Ratio: 0.30
Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: 0.01
Estmated Long-Term EPS Growth Rate: 10.96% Last Dividend Paid: 02/24/2022 - $0.28
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 17.89
Trailing 12 Months: 19.61
PEG Ratio: 1.63
Price Ratios
Price/Book: 4.10
Price/Cash Flow: 13.65
Price / Sales: 2.76
EPS Growth
vs. Year Ago Period: 22.37%
vs. Previous Quarter: -10.58%
Sales Growth
vs. Year Ago Period: 25.83%
vs. Previous Quarter: 5.49%
ROE
03/31/22 - 21.59
12/31/21 - 21.01
09/30/21 - 19.94
ROA
03/31/22 - 7.27
12/31/21 - 7.94
09/30/21 - 8.73
Current Ratio
03/31/22 - 2.10
12/31/21 - 2.09
09/30/21 - 2.37
Quick Ratio
03/31/22 - 1.45
12/31/21 - 1.52
09/30/21 - 1.78
Operating Margin
03/31/22 - 14.18
12/31/21 - 14.36
09/30/21 - 13.84
Net Margin
03/31/22 - 7.80
12/31/21 - 10.04
09/30/21 - 9.75
Pre-Tax Margin
03/31/22 - 9.01
12/31/21 - 11.55
09/30/21 - 11.28
Book Value
03/31/22 - 18.11
12/31/21 - 18.22
09/30/21 - 17.61
Inventory Turnover
03/31/22 - 3.62
12/31/21 - 3.59
09/30/21 - 3.77
Debt-to-Equity
03/31/22 - 1.84
12/31/21 - 1.88
09/30/21 - 0.62
Debt-to-Capital
03/31/22 - 64.77
12/31/21 - 65.28
09/30/21 - 38.19
 

Powered by Zacks Investment Research ©